These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14741002)

  • 1. Retinoblastoma and tumor-suppressor gene therapy.
    Xu HJ
    Ophthalmol Clin North Am; 2003 Dec; 16(4):621-9. PubMed ID: 14741002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H; Wei F; Li H; Ji X; Li S; Chen X
    Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of rAAV2-RB1-Mediated Gene Therapy in Retinoblastoma.
    Shi H; He X; Yang Z; Liao Q; Ruan J; Ge S; Chai P; Jia R; Fan J; Wen X; Fan X
    Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):31. PubMed ID: 38133505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental research on in vivo gene-therapy of retinoblastoma].
    Chen D; Zhang X; Luo C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Aug; 16(4):211-5. PubMed ID: 10431044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p107 is a suppressor of retinoblastoma development in pRb-deficient mice.
    Robanus-Maandag E; Dekker M; van der Valk M; Carrozza ML; Jeanny JC; Dannenberg JH; Berns A; te Riele H
    Genes Dev; 1998 Jun; 12(11):1599-609. PubMed ID: 9620848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulated differentiation of WERI-Rb-1 cells into retinal neuron-like cells.
    Liu Y; Hu H; Liang M; Xiong Y; Li K; Chen M; Fan Z; Kuang X; Deng F; Liu X; Xu C; Li K; Ge J
    Int J Mol Med; 2017 Oct; 40(4):1172-1184. PubMed ID: 28848998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoblastoma: from discovery to clinical management.
    Martínez-Sánchez M; Hernandez-Monge J; Rangel M; Olivares-Illana V
    FEBS J; 2022 Aug; 289(15):4371-4382. PubMed ID: 34042282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leiomyosarcoma of the bladder in a retinoblastoma patient.
    Bléoo SL; Godbout R; Rayner D; Tamimi Y; Moore RB
    Urol Int; 2003; 71(1):118-21. PubMed ID: 12845276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-145 suppressed human retinoblastoma cell proliferation and invasion by targeting ADAM19.
    Sun Z; Zhang A; Jiang T; Du Z; Che C; Wang F
    Int J Clin Exp Pathol; 2015; 8(11):14521-7. PubMed ID: 26823772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on thymidine kinase gene (TK) and GCV system for treatment of human retinoblastoma (RB)].
    Liu J; Jing H; Zhang W; Liao S; Huang Q
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):300-3. PubMed ID: 12545814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular biology of retinoblastoma.
    Brantley MA; Harbour JW
    Ocul Immunol Inflamm; 2001 Mar; 9(1):1-8. PubMed ID: 11262663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mir-138-5p acts as a tumor suppressor by targeting pyruvate dehydrogenase kinase 1 in human retinoblastoma.
    Wang Z; Yao YJ; Zheng F; Guan Z; Zhang L; Dong N; Qin WJ
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5624-5629. PubMed ID: 29271995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rb pathway and cancer therapeutics.
    Du W; Searle JS
    Curr Drug Targets; 2009 Jul; 10(7):581-9. PubMed ID: 19601762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101.
    Song X; Zhou Y; Jia R; Xu X; Wang H; Hu J; Ge S; Fan X
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2626-35. PubMed ID: 20007825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of adenomatosis polyposis coli-2 and its tumor suppressor role in retinoblastoma.
    Beta M; Chitipothu S; Khetan V; Biswas J; Krishnakumar S
    Curr Eye Res; 2015 Jul; 40(7):719-28. PubMed ID: 25207834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNAs as potential game-changers in retinoblastoma: Future clinical and medicinal uses.
    Doghish AS; Moustafa HAM; Elballal MS; Sarhan OM; Darwish SF; Elkalla WS; Mohammed OA; Atta AM; Abdelmaksoud NM; El-Mahdy HA; Ismail A; Abdel Mageed SS; Elrebehy MA; Abdelfatah AM; Abulsoud AI
    Pathol Res Pract; 2023 Jul; 247():154537. PubMed ID: 37216745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RB protein family in retinal development and retinoblastoma: new insights from new mouse models.
    Bremner R; Chen D; Pacal M; Livne-Bar I; Agochiya M
    Dev Neurosci; 2004; 26(5-6):417-34. PubMed ID: 15855771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
    Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retinoblastoma].
    Kaneko A
    Nihon Rinsho; 2000 Jul; 58(7):1413-8. PubMed ID: 10921315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic adenovirus delivering herpes simplex virus thymidine kinase suicide gene reduces the growth of human retinoblastoma in an in vivo mouse model.
    Ji X; Zhang J; Cheng L; Wei F; Li H; Liu X; Chen X; Li C; Wang Y; Huang Q
    Exp Eye Res; 2009 Aug; 89(2):193-9. PubMed ID: 19328781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.